CanaQuest Medical Corp
CanaQuest Medical Corp. develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils. The company was formerly known as Algae Dynamics Corp. and changed its name to CanaQuest Medical Corp. in January 2019. CanaQuest Medical Corp. was founded in 2008 and is based in Mississauga, Canada.
CanaQuest Medical Corp (CANQF) - Net Assets
Latest net assets as of December 2024: $-807.37K USD
Based on the latest financial reports, CanaQuest Medical Corp (CANQF) has net assets worth $-807.37K USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($139.88K) and total liabilities ($947.25K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-807.37K |
| % of Total Assets | -577.19% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CanaQuest Medical Corp - Net Assets Trend (2014–2024)
This chart illustrates how CanaQuest Medical Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CanaQuest Medical Corp (2014–2024)
The table below shows the annual net assets of CanaQuest Medical Corp from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $-1.11 Million | -9.88% |
| 2023-03-31 | $-1.01 Million | -46.66% |
| 2022-03-31 | $-686.74K | -5.61% |
| 2021-03-31 | $-650.29K | -29.02% |
| 2020-03-31 | $-504.01K | +39.85% |
| 2018-03-31 | $-837.93K | -4.13% |
| 2017-03-31 | $-804.69K | -14.94% |
| 2016-03-31 | $-700.10K | +6.89% |
| 2015-03-31 | $-751.94K | -90.94% |
| 2014-03-31 | $-393.80K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CanaQuest Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1201327400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $6.15 Million | % |
| Other Comprehensive Income | $835.92K | % |
| Other Components | $4.65 Million | % |
| Total Equity | $-1.11 Million | 100.00% |
CanaQuest Medical Corp Competitors by Market Cap
The table below lists competitors of CanaQuest Medical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Crescent Textile Mills Ltd
KAR:CRTM
|
$2.12K |
|
NARA KIC Inc.
KQ:007460
|
$2.12K |
|
INTERNATIONAL ELITE
BE:3IE1
|
$2.13K |
|
Lexington Gold Ltd
LSE:LEX
|
$2.13K |
|
JHS Svendgaard Retail Ventures Limited
NSE:RETAIL
|
$2.12K |
|
Ekiosk
WAR:EKS
|
$2.12K |
|
Indus Gas Limited
LSE:INDI
|
$2.12K |
|
ATMP3F
SA:ATMP3F
|
$2.12K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CanaQuest Medical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -1,007,173 to -1,106,692, a change of -99,519.
- Net loss of 1,385,833 reduced equity.
- Other comprehensive income increased equity by 314,033.
- Other factors increased equity by 972,281.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.39 Million | -125.22% |
| Other Comprehensive Income | $314.03K | +28.38% |
| Other Changes | $972.28K | +87.85% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares CanaQuest Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | $-0.05 | $0.02 | x |
| 2015-03-31 | $-0.08 | $0.02 | x |
| 2016-03-31 | $-0.07 | $0.02 | x |
| 2017-03-31 | $-0.07 | $0.02 | x |
| 2018-03-31 | $-0.06 | $0.02 | x |
| 2020-03-31 | $-0.03 | $0.02 | x |
| 2021-03-31 | $-0.03 | $0.02 | x |
| 2022-03-31 | $-0.03 | $0.02 | x |
| 2023-03-31 | $-0.05 | $0.02 | x |
| 2024-03-31 | $-0.05 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CanaQuest Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4093.07%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-193.58K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.01 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.84 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.51 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.02 Million |
| 2020 | 0.00% | -4332.07% | 0.43x | 0.00x | $-845.78K |
| 2021 | 0.00% | -20670.53% | 0.04x | 0.00x | $-137.14K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-528.46K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-732.11K |
| 2024 | 0.00% | -4093.07% | 0.16x | 0.00x | $-1.28 Million |
Industry Comparison
This section compares CanaQuest Medical Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CanaQuest Medical Corp (CANQF) | $-807.37K | 0.00% | N/A | $2.12K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |